Cryo-Save Group
Cryo-Save Group is active in cord blood banking since 2000 and has a leading position in this field in Europe. The Cryo-Save Group is active in different European countries and is focusing its strategy on cell banking applications.
As service provider in stem cell banking, Cryo-Save Group stores umbilical cord blood stem cells and bone marrow stem cells. The group has about 40 employees, and has extensive expertise in banking technology and cryopreservation of biological material.
Because of the growing activities in cell therapy more developments are done towards application on SC therapies (expansion CD34).
 |
| Stem cell banking will need more appropriate technologies in cryopreservation |
Activities are focused on:
- Stem cell banking: cryopreservation of stem cells of different sources, mainly UCB
- The quality criteria which are important in banking systems
- International technology transfer of stem cell banking
- Development of a cell culture system to maintain and cryopreserve different cell types.
Guy Wouters
PhD in biological science, biotechnology for health care. Diploma in Cellular Therapy (Mulhouse, France). Following scientific evolution in Stem Cell Therapy and active in cell banking methods. Active participation in set up of international cord blood banks.
Background in clinical research, diagnostics, virology and molecular biology and genetics.
Developments in chemical analysis and biochemical interactions with cell structure and cryobiology is of main interest.
Albert Ramon
- He is a consultant at the University Hospital Antwerp Department of Gastroenterohepatology.
- He is a guest lector at the University Houston (USA) Texas Medical school department of Immunopathology.
- He is a consultant at the Institute of Genetics and Molecular Pathology in Cologne (G).
- Co-founder of ECMTA (European Center of Medical and Technical Applications) Cologne.
- Recently he has been nominated as guest senior researcher in the department of Urology at the Lucas Hospital Duesseldorf- Neuss.
- Co-investigator in the International IVIG Study Group in ARC patients (AIDS) (1984-1987).
- Akzo-Nobel (Organon Teknika) partner in Research Award (1992).
- Genzyme recognition and contribution to research and development purposes Award (1994).
- Patent holder on CMV antigen and its use in vaccination and diagnostic purposes (1996).
- WHO's WHO International of Professionals selection (1998).
- Founder of the International collaborating Group on Onco vaccination (AIMO) (1999).
- Founder and chairman of the International Tissue Engineering Research Association (ITERA) (2004).
- Member of the EASL, BASL, ISSCR, GSZ.
- Member of the Advisory Committee of ISSAC.
- Author and co-author of different publications and peer reviewed publications.
- He was a fellow at the National Institute of Health in 1986 at the Laboratory of Cellular and Molecular Biology ( Prof Dr R Gallo) Research project on HHV 6 Coordinators Prof Dr D. Ablashi and Prof Dr GRF Krueger.
Contact:
Dr. ir. Guy Wouters
Research and Development Manager
Cryo-Save Group
Generaal De Wittelaan 19B
B-2800 Mechelen
T: +32 (0)15 - 27 44 96
F: +32 (0)15 - 27 51 45
Website: www.cryo-savegroup.com
